Myeloma Center

Bibliography

Found 1 results
Author Title Type [ Year(Asc)]
Filters: Author is Goldschmidt, Hartmut and Keyword is Drug Administration Schedule  [Clear All Filters]
2017
Dimopoulos MA, Goldschmidt H, Niesvizky R, Joshua D, Chng W-J, Oriol A, Orlowski RZ, Ludwig H, Facon T, Hajek R et al..  2017.  Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.. Lancet Oncol. 18(10):1327-1337.